Dopamine agonists in the treatment of prolactinoma: are they still first choice?

Autor:	Cara M. Ogilvie, Stella R. Milsom
Rok vydání:	2011
Předmět:	medicine.medical_specialty business.industry Disease medicine.disease Dopamine agonist Prolactin Endocrinology Dopamine Internal medicine Internal Medicine Prolactin excess Medicine business Prolactinoma medicine.drug
Zdroj:	Internal Medicine Journal. 41:156-161
ISSN:	1444-0903
DOI:	10.1111/j.1445-5994.2010.02410.x
Popis:	Dopamine agonist therapy has been the cornerstone treatment for prolactinoma since the 1970s, replacing surgery in the primary management of this condition. These agents are effective in the management of prolactin excess, have a low side-effect profile, and in some cases may even be curative. However, recent studies of high dose dopamine agonists used in Parkinson's disease have raised the possibility that these drugs may be associated with cardiac valvulopathy. This paper discusses the modern use of dopamine agonists in a patient with prolactinoma.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::49e7ba9f44597c13169eb9f0fe0e0359 https://doi.org/10.1111/j.1445-5994.2010.02410.x Zobrazit plný text záznamu Plný text